MIVetsCan: Can-Coach Trial (Phase 1)
MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 1)
2 other identifiers
interventional
22
1 country
1
Brief Summary
The goal of the MIVetsCan Can-Coach Trial is to pilot and modify a trial of four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Aug 2023
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2023
CompletedFirst Submitted
Initial submission to the registry
February 21, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedMarch 20, 2024
March 1, 2024
4 months
February 21, 2024
March 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Global Impression of Change (PGIC) score
Patient's Global Impression of Change (PGIC) scale will be used. This is a 7 point scale ranging from 1 (very much worse) to 7 (very much better).
Week 14
Secondary Outcomes (2)
Average satisfaction level of the cannabis coaching overall assessed from a single survey question on satisfaction.
Following intervention, up to approximately Week 14
Average helpfulness level of the cannabis coaching assessed from a single survey question on cannabis coaching.
Following intervention, up to approximately Week 14
Study Arms (1)
Education
EXPERIMENTALPrior to the educational sessions, study participants will be given access to educational materials (e.g., handouts, videos) that provide an overview of information regarding cannabis products, effects, and pain. These materials will be developed with insight from the study team and the Community Advisory Board. Educational content will include known side effects of cannabis (e.g., common effects like dizziness or sedation, rare side effects like hallucinations or vomiting) as well as specific risks associated with administration routes, such as respiratory harm from smoking or unregulated vaporized concentrate products, and the delayed onset of edible products. Sessions will help the participants appropriately select products for use.
Interventions
The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.
Eligibility Criteria
You may qualify if:
- United States Veteran
- Experiencing chronic pain (pain lasting 3 or more months)
- Worst pain of ≥3 out of 10 using a 0-10 Numeric Rating Scale (NRS)
- Are planning or currently using cannabidiol (CBD) or cannabis products for pain management
- Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions
- Willingness to attend all study visits (conducted virtually)
- Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details)
You may not qualify if:
- Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English)
- Participant states participant is pregnant
- Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition)
- Current diagnosis or past history of bipolar disorder
- Unable to attend study visits
- Risk for eminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members
- Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Boehnke KF, Bowyer G, McAfee J, Smith T, Klida C, Kurtz V, Litinas E, Purohit P, Arewasikporn A, Horowitz D, Thomas L, Eckersley J, Railing M, Williams DA, Clauw DJ, Kidwell KM, Bohnert ASB, Bergmans RS. Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans. J Cannabis Res. 2025 Jan 25;7(1):7. doi: 10.1186/s42238-025-00265-z.
PMID: 39856785DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kevin Boehnke, PhD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor, Anesthesiology
Study Record Dates
First Submitted
February 21, 2024
First Posted
March 20, 2024
Study Start
August 7, 2023
Primary Completion
December 11, 2023
Study Completion
December 11, 2023
Last Updated
March 20, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share